FIRST TRUST ADVISORS LP – Alnylam Pharmaceuticals, Inc. Transaction History
FIRST TRUST ADVISORS LP portfolio value:
$99.06M
portfolio value
FIRST TRUST ADVISORS LP quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +23.77% | 95.06K shares | 40.74M | $200.16 | 494.93K |
| Q2 2022 | share | Decrease | -0.69% | -2.78K shares | -7.42M | $145.85 | 399.86K |
| Q1 2022 | share | Decrease | -20.60% | -104.44K shares | -20.24M | $163.29 | 402.65K |
| Q4 2021 | share | Decrease | -4.73% | -25.19K shares | -14.50M | $171.03 | 507.09K |
| Q3 2021 | share | Increase | +5.21% | 26.36K shares | 14.73M | $188.81 | 532.28K |
| Q2 2021 | share | Increase | +17.08% | 73.79K shares | 24.75M | $169.52 | 505.92K |
| Q1 2021 | share | Decrease | -23.19% | -130.49K shares | -12.11M | $141.19 | 432.13K |
| Q4 2020 | share | Decrease | -22.46% | -162.98K shares | -32.52M | $129.97 | 562.62K |
| Q3 2020 | share | Decrease | -10.37% | -83.95K shares | -14.25M | $145.6 | 725.61K |
| Q2 2020 | share | Decrease | -4.45% | -37.66K shares | 27.68M | $148.11 | 809.56K |
| Q1 2020 | share | Increase | +41.63% | 249.01K shares | 23.32M | $108.85 | 847.23K |
| Q4 2019 | share | Decrease | -25.56% | -205.45K shares | 4.26M | $115.17 | 598.21K |
| Q3 2019 | share | Decrease | -30.31% | -349.57K shares | -19.04M | $80.42 | 803.66K |
| Q2 2019 | share | Decrease | -3.29% | -39.25K shares | -27.76M | $72.56 | 1.15M |
| Q1 2019 | share | Increase | +1.23% | 14.43K shares | 25.54M | $93.45 | 1.19M |
| Q4 2018 | share | Increase | +25.72% | 241.03K shares | 3.88M | $72.91 | 1.17M |
| Q3 2018 | share | Increase | +42.02% | 277.25K shares | 17.02M | $87.52 | 937.02K |
| Q2 2018 | share | Increase | +22.94% | 123.09K shares | 1.06M | $98.49 | 659.76K |
| Q1 2018 | share | Decrease | -6.08% | -34.73K shares | -8.67M | $119.1 | 536.66K |
| Q4 2017 | share | Decrease | -27.18% | -213.22K shares | -19.58M | $127.05 | 571.39K |
| Q3 2017 | share | Increase | +25.27% | 158.28K shares | 42.22M | $117.49 | 784.61K |
| Q2 2017 | share | Decrease | -9.77% | -67.85K shares | 14.37M | $79.76 | 626.33K |
| Q1 2017 | share | Decrease | -5.99% | -44.22K shares | 7.93M | $51.25 | 694.18K |
| Q4 2016 | share | Increase | +75.40% | 317.43K shares | -888K | $37.44 | 738.40K |
| Q3 2016 | share | Increase | +0.89% | 3.72K shares | 5.38M | $67.78 | 420.97K |
| Q2 2016 | share | Decrease | -9.47% | -43.63K shares | -5.77M | $55.49 | 417.24K |
| Q1 2016 | share | Decrease | -62.33% | -762.65K shares | -86.25M | $62.77 | 460.88K |